Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 604-636-5 | CAS number: 148477-71-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Version / remarks:
- not specified
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- Previously known as '92/69/EEC B.10'
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 3-(3,5-Dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutanoate
- Cas Number:
- 148477-71-8
- Molecular formula:
- C21H24Cl2O4
- IUPAC Name:
- 3-(3,5-Dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutanoate
- Test material form:
- not specified
1
Method
- Target gene:
- Not applicable
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Cytokinesis block (if used):
- 0.2 mL Colcemid-solution (40 ug/mL water) was added to each flask two hours prior to the end of the incubation period to arrest the cells in a metaphase-like stage of mitosis (c-metaphase).
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix was used for the simulation of the mammalian metabolism. The S9 fraction was isolated from the livers of Aroclor 1254 induced Wistar rats.
- Test concentrations with justification for top dose:
- 5, 10, 20, 40, and 80 µg/mL without S9 mix.
10, 20, 40, 80 and 160 µg/mL with S9 mix.
Additional experiment: 0.75, 1.5, 3, 6 and 12 µg/ml without S9 mix.
Limited by cytotoxicity - Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- Spirodiclofen was tested for a clastogenic potential in an in vitro chromosome aberration test. Chinese Hamster V79 cells were exposed for 4 hours to spirodiclofen concentrations of 5, 10, 20, 40, and 80 µg/mL without S9 mix. With S9 mix 10, 20, 40, 80 and 160 µg/mL were used. In an additional performed experiment cells were exposed in the absence of S9 mix for 4 hours to concentrations of 0.75, 1.5, 3, 6 and 12 µg/ml of spirodiclofen. The positive controls were mitomycin C and cyclophosphamide.
- Rationale for test conditions:
- Test concentrations were based on the results of a preliminary assay.
- Evaluation criteria:
- An increased incidence of gaps of both types without concomitant increase of other aberration types was not considered as indication of a clastogenic effect. A test was considered positive if there was a relevant and statistically significant increase in the aberration rate. A test was considered negative if there was no such increase at any time interval. A test was considered equivocal if there was an increase which was statistically significant but not considered relevant,
or if an increase occurred, which was considered relevant, but which was not statistically significant. An assay was acceptable if there was a biologically relevant increase in chromosome aberrations induced by the positive controls and if the numbers of aberrations for the negative controls were in the expected range based on results from the laboratory and from published studies. - Statistics:
- The statistical analysis was performed by pair-wise comparison of treated and positive control groups to the respective solvent control group. The mitotic index was statistically analyzed (provided that it was reduced compared to the respective negative control mean) using the one-sided chi-squared test. The numbers of metaphases with aberrations (including and excluding
gaps) and of metaphases with exchanges were compared (provided that these data superseded the respective negative control). The statistical analysis followed the recommendations outlined by Richardson et al. (1989). Fisher's exact test was used for the statistical evaluation. A difference was considered to be significant if the probability of error was below 5 %.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at >0.75 µg/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at >20 µg/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Without S9 mix, statistically significant values for the numbers of metaphases with aberrations were detected for 3 ug/mL and a culture time of 18 hours. These values were, however, within the range of historical negative controls. In addition, they were equal to the results of the untreated control for cultures harvested after a culture time of 30 hours, Therefore, these significances were not considered relevant. None of the other cultures neither after 18 nor after 30 hours culture time showed statistically significant or biologically relevant increased numbers of metaphases with aberrations. The treatment with the positive control mitomycin C resulted in a clear and statistically significant increase of metaphases with aberrations and demonstrated the sensitivity of the test system.
With S9 mix, no biologically relevant and statistically significant increases of metaphases with aberrations were detected after total culture times of 18 hours. For cultures treated with 80 ug/mL and terminated after a culture time of 30 hours significant values were observed for metaphases with aberrations. However, these values were within the range of historical negative controls and were, therefore, not regarded as a biologically relevant indication of a clastogenic effect. The positive control cyclophosphamide induced statistically significant and biologically relevant increases of metaphases with aberrations and demonstrated the sensitivity of the test
system and the activity of the used S9 mix.
Any other information on results incl. tables
Summary of results
Concentration (µg/mL) | Metaphases with aberrations (%) | |||
-S9 | +S9 | |||
18 hours | 30 hours | 18 hours | 30 hours | |
0 (DMSO) | 1.0 | 4.5 | 3.5 | 2.5 |
0 (untreated) | 1.5 | - | 4.5 | - |
0.75 | 1.5 | - | - | - |
1.5 | 2.5 | - | - | - |
3 | 4.5* | 4.0 | - | - |
20 | - | - | 1.5 | - |
40 | - | - | 3.5 | - |
80 | - | - | 2.0 | - |
MMC | 44.0** | - | - | - |
CPA | - | - | 19.0* | 7.0* |
*significantly different to controls (p<0.05); **p<0.01)
Applicant's summary and conclusion
- Conclusions:
- No evidence of clastogenicity was seen under the conditions of this study.
- Executive summary:
Spirodiclofen was tested for a clastogenic potential in an in vitro chromosome aberration test. Chinese Hamster V79 cells were exposed for 4 hours to concentrations of 5, 10, 20, 40, and 80 μg/mL without S9 mix. With S9 mix 10, 20, 40, 80 and 160 μg/mL were used. In an additional performed experiment cells were exposed in the absence of S9 mix for 4 hours to concentrations of 0.75, 1.5, 3, 6 and 12 μg/mL of spirodiclofen. The positive controls were mitomycin C (-S9) and cyclophosphamide (+S9). Cytotoxic effects were seen at 0.75 μg/mL and above (-S9) and at 20 μg/mL and above (+S9). None of the cultures treated with spirodiclofen in the absence and in the presence of S9 showed biologically relevant increased numbers of aberrant metaphases. The positive controls demonstrated a good sensitivity of this test system. In conclusion, spirodiclofen was not considered to be clastogenic for mammalian cells with and without metabolic activation in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.